Correlation Between Viridian Therapeutics and Fresh2
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Fresh2 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Fresh2 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Fresh2 Group, you can compare the effects of market volatilities on Viridian Therapeutics and Fresh2 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Fresh2. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Fresh2.
Diversification Opportunities for Viridian Therapeutics and Fresh2
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Viridian and Fresh2 is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Fresh2 Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fresh2 Group and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Fresh2. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fresh2 Group has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Fresh2 go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Fresh2
Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 0.44 times more return on investment than Fresh2. However, Viridian Therapeutics is 2.28 times less risky than Fresh2. It trades about 0.04 of its potential returns per unit of risk. Fresh2 Group is currently generating about -0.04 per unit of risk. If you would invest 1,690 in Viridian Therapeutics on September 4, 2024 and sell it today you would earn a total of 410.00 from holding Viridian Therapeutics or generate 24.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Fresh2 Group
Performance |
| Timeline |
| Viridian Therapeutics |
| Fresh2 Group |
Viridian Therapeutics and Fresh2 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Fresh2
The main advantage of trading using opposite Viridian Therapeutics and Fresh2 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Fresh2 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fresh2 will offset losses from the drop in Fresh2's long position.| Viridian Therapeutics vs. Candel Therapeutics | Viridian Therapeutics vs. Cingulate Warrants | Viridian Therapeutics vs. Unicycive Therapeutics | Viridian Therapeutics vs. Cardio Diagnostics Holdings |
| Fresh2 vs. WiMi Hologram Cloud | Fresh2 vs. Analog Devices | Fresh2 vs. Arrow Electronics | Fresh2 vs. Uber Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets |